395 related articles for article (PubMed ID: 12200702)
21. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
22. Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.
Mitomi H; Fukui N; Kishimoto I; Tanabe S; Kikuchi S; Saito T; Hayashi T; Yao T
Hum Pathol; 2011 Oct; 42(10):1505-13. PubMed ID: 21496871
[TBL] [Abstract][Full Text] [Related]
23. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
24. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
25. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
26. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma.
Tsuda H; Yamamoto K; Inoue T; Uchiyama I; Umesaki N
Br J Cancer; 2000 Feb; 82(3):675-82. PubMed ID: 10682682
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
[TBL] [Abstract][Full Text] [Related]
28. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
29. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
30. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
31. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
33. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
34. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168
[TBL] [Abstract][Full Text] [Related]
37. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Papadimitrakopoulou VA; Izzo J; Mao L; Keck J; Hamilton D; Shin DM; El-Naggar A; den Hollander P; Liu D; Hittelman WN; Hong WK
Clin Cancer Res; 2001 Oct; 7(10):3127-34. PubMed ID: 11595705
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
Park HW; Song SY; Lee TJ; Jeong D; Lee TY
Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]